Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
EASTONS FINANCIAL STATEMENTS AS WELL AS THEIR PRESS RELEASES WERE ALL VERIFIED BY FINRA!!
!!EASTON SET TO ROLL WITH SIGNIFICANT ANNOUNCEMENTS PENDING. !!
HERE ARE THE FACTS ON EAPH.
it's now too late for anyone to stop what has been set in motion and what is going to happen with the company and its business .
Easton has advanced funds for LEGITIMATE acquisitions that are soon going to generate millions of dollars in profits on top of advancing funds towards licensing.
Gedeon Richter did sign an agreement with Easton / EAPH and is selling product on behalf of themselves and Easton/BMV. They have 11,000 employees and have billions in revenues.
Congratulations to Windsor pharmaceuticals as they just spent a whole year getting regulatory approval for those products for Central America with 55,000,000 people and were now successful. Product is going to be delivered in the next few weeks and they will be selling very shortly.
Easton has not had any shares issued in over 2 years. That means ZERO dilution!
As Easton stated, ALLIANCE / EASTON HAS CONTRACTS IN PLACE FOR THEIR AGGREGATE BUSINESS. ITS GUARANTEED REVENUES FOR EASTON. EASTON HAS THE OPTION TO GO INTO MMJ OR AGGREGATE AND POSSIBLY BOTH. THE STOCK IS WAY UNDERVALUED COMPARED TO MANY OTHERS BASED ON FUTURE REVENUES
I predict that Your going to soon get another big run up starting with the Bayer announcement . I predict that Very shortly big money will again be flowing into EAPH making EAPH the big play once again except this time it will have sustained new highs based on value and forward sales . New highs will be broken on its way to $.20 cents or higher.
Let's look at some things Easton currently has:
•. $400K in sales in the last quarter from its distribution partners Gedeon Richter who by the way have 11,000 employees and billions in revenues.
•. Sales will now be starting in Central America With Windsor Pharmaceuticals who just received regulatory approval to sell the same products.
• Third product launch shortly at hand through Bayer Pharmaceuticals who are selling VS-Sense in Europe. They now want Mexico and Latin America which Easton currently has the rights to so that will get finalized and once announced watch out.
•. Alliance partners agreement has guaranteed revenues stream secured through property. Medical marijuana approval might soon be announced but they already have contracts announced for the Aggregate business which will not start until they receive a response regarding their medical marijuana initiatives for Canada so not to impair MMJ which will have an answer by the end of this month. By the end of the month we should hear some very good news.
• iBliss is on board with everything which Easton has indicated they appreciated iBliss's patience as they can see the value with Alliance Group.
My friends the big run with new highs is soon here as too many catalysts to ignore. This company will not be undervalued for much longer.
Do your own due diligence and speak to the company about getting accurate information. This includes reading their financial statements and press releases very closely . 3 weeks ago, Easton went up by 50% in a week. That will soon be smalltime returns.
!!EVAN KARRAS HAS DONE A GREAT JOB AND IS SET TO ROLL EAPH WITH SIGNIFICANT ANNOUNCEMENTS. !!
HERE ARE THE COLD HARD FACTS OF EAPH. IT CAN BE CHECKED BY READING THEIR FINANCIAL STATEMENTS AND EMAILING THE COMPANY
it's now too late as no one will be able to stop what has been set in motion and what is going to happen with the company and its business.
Easton has advanced funds for LEGITIMATE acquisitions that are soon going to generate millions of dollars in profits on top of advancing funds towards licensing. CONTRACTS ALREADY ANNOUNCED
Gedeon Richter did sign an agreement with Easton / EAPH and is selling product on behalf of themselves and Easton/BMV. ( 2 Products) They have 11,000 employees and have billions in revenues so I would say that they are a pretty good partner.
Congratulations to Windsor pharmaceuticals as they just spent a whole year getting regulatory approval for those products for Central America with 55,000,000 people and were now successful. Product is going to be delivered in the next few weeks and they will be selling very shortly. Let's just focus on facts .
Easton has not had any shares issued in over 2 years. That means ZERO DILUTION !
Easton has raised $1.7 million through private investors which represents an acceptance of Easton's business. This is all done with ZERO DILUTION!
As Easton stated, ALLIANCE / EASTON HAS CONTRACTS IN PLACE FOR THEIR AGGREGATE BUSINESS. ITS GUARANTEED REVENUES FOR EASTON. EASTON HAS THE OPTION TO GO INTO MMJ OR AGGREGATE . THE STOCK IS WAY UNDERVALUED COMPARED TO MANY OTHERS BASED ON FUTURE REVENUES
I predict that Your going to soon get another big run up starting with the Bayer announcement . I predict that Very shortly big money will again be flowing into EAPH making EAPH the big play once again except this time it will have sustained new highs based on value and forward sales . New highs will be broken on its way to $.20 cents or higher.
Let's look at some things Easton currently has:
•. $400K in sales in the last quarter from its distribution partners Gedeon Richter who by the way have 11,000 employees and billions in revenues.
•. Sales will now be starting in Central America With Windsor Pharmaceuticals who just received regulatory approval to sell the same products. Products were ordered for first order.
• Third product launch shortly at hand through Bayer Pharmaceuticals who are selling VS-Sense in Europe. They now want Mexico and Latin America which Easton currently has the rights to so that will get finalized and once announced WATCH OUT!.
•. Alliance partners agreement has guaranteed revenues stream secured through property. Medical marijuana approval might soon be announced early in October but they already have contracts announced for the Aggregate business which will not start until they receive a response regarding their medical marijuana initiatives for Canada which will have an answer by the end of this month. By the end of the month we should hear some very good news.
• iBliss is on board with everything which Easton has indicated they appreciated iBliss's patience as they can see the value with Alliance Group.
My friends the big run with new highs is soon here as too many catalysts to ignore. This company will not be undervalued for much longer.
Do your own due diligence and speak to the company about getting accurate information. This includes reading their financial statements and press releases very closely . 3 weeks ago, Easton went up by 50% in a week. That will soon be smalltime returns.
!!EASTON SET TO ROLL WITH SIGNIFICANT ANNOUNCEMENTS PENDING AS PER TWEET. !!
HERE ARE THE COLD HARD FACTS OF EAPH. IT CAN BE CHECKED BY READING THEIR FINANCIAL STATEMENTS AND EMAILING THE COMPANY
it's now too late as no one will be able to stop what has been set in motion and what is going to happen with the company progressing with its business plan.
Easton has advanced funds for LEGITIMATE acquisitions that are soon going to generate millions of dollars in profits on top of advancing funds towards licensing.
Gedeon Richter did sign an agreement with Easton / EAPH and is selling product on behalf of themselves and Easton/BMV. They have 11,000 employees and have billions in revenues.
Congratulations to Windsor pharmaceuticals as they just spent a whole year getting regulatory approval for those products for Central America with 55,000,000 people and were now successful. Product is going to be delivered in the next few weeks and they will be selling very shortly. People can say what they wish but can we at least stop flagrant misinformation .
Easton has not had any shares issued in over 2 years. That means ZERO dilution!
As Easton stated, ALLIANCE / EASTON HAS CONTRACTS IN PLACE FOR THEIR AGGREGATE BUSINESS. ITS GUARANTEED REVENUES FOR EASTON. EASTON HAS THE OPTION TO GO INTO MMJ OR AGGREGATE . THE STOCK IS WAY UNDERVALUED COMPARED TO MANY OTHERS BASED ON FUTURE REVENUES
I predict that Your going to soon get another big run up starting with the Bayer announcement . I predict that Very shortly big money will again be flowing into EAPH making EAPH the big play once again except this time it will have sustained new highs based on value and forward sales . New highs will be broken on its way to $.20 cents or higher.
Let's look at some things Easton currently has:
•. $400K in sales in the last quarter from its distribution partners Gedeon Richter who by the way have 11,000 employees and billions in revenues.
•. Sales will now be starting in Central America With Windsor Pharmaceuticals who just received regulatory approval to sell the same products.
• Third product launch shortly at hand through Bayer Pharmaceuticals who are selling VS-Sense in Europe. They now want Mexico and Latin America which Easton currently has the rights to so that will get finalized and once announced watch out.
•. Alliance partners agreement has guaranteed revenues stream secured through property. Medical marijuana approval might soon be announced but they already have contracts announced for the Aggregate business which will not start until they receive a response regarding their medical marijuana initiatives for Canada which will have an answer by the end of this month. By the end of the month we should hear some very good news.
• iBliss is on board with everything which Easton has indicated they appreciated iBliss's patience as they can see the value with Alliance Group.
My friends the big run with new highs is soon here as too many catalysts to ignore. This company will not be undervalued for much longer.
Do your own due diligence and speak to the company about getting accurate information. This includes reading their financial statements and press releases very closely . 3 weeks ago, Easton went up by 50% in a week. That will soon be smalltime returns.
Replies:
You coverd everything 007 ty for your time
traderjack1 on 9/19/2017 11:05:32 AM
Report TOS
500% returns from 1 year ago today . A year ago EAPH was trading at $0.005 cents. Anyone who bought at that time made a huge profit. If those people sold at its peak it was a 1000% return.
If Easton gets what they're waiting to get hopefully today or tomorrow, everyone will be extremely upset they did not hold any shares of the stock today.
I will say it again, if Easton gets what they're hoping to get in the next day or two, everyone will be kicking themselves that they did not own Easton stock today.
By the way, the company owned by Alliance group, is 1124123 Ontario Inc.
!!EASTON SET TO ROLL WITH SIGNIFICANT ANNOUNCEMENTS PENDING. !!
HERE ARE THE COLD HARD FACTS OF EAPH. IT CAN BE CHECKED BY READING THEIR FINANCIAL STATEMENTS AND EMAILING THE COMPANY
it's now too late as no one will be able to stop what has been set in motion and what is going to happen with the company progressing with its business plan.
Easton has advanced funds for LEGITIMATE acquisitions that are soon going to generate millions of dollars in profits on top of advancing funds towards licensing.
Gedeon Richter did sign an agreement with Easton / EAPH and is selling product on behalf of themselves and Easton/BMV. They have 11,000 employees and have billions in revenues.
Congratulations to Windsor pharmaceuticals as they just spent a whole year getting regulatory approval for those products for Central America with 55,000,000 people and were now successful. Product is going to be delivered in the next few weeks and they will be selling very shortly. People can say what they wish but can we at least stop flagrant misinformation .
Easton has not had any shares issued in over 2 years. That means ZERO dilution!
As Easton stated, ALLIANCE / EASTON HAS CONTRACTS IN PLACE FOR THEIR AGGREGATE BUSINESS. ITS GUARANTEED REVENUES FOR EASTON. EASTON HAS THE OPTION TO GO INTO MMJ OR AGGREGATE . THE STOCK IS WAY UNDERVALUED COMPARED TO MANY OTHERS BASED ON FUTURE REVENUES
I predict that Your going to soon get another big run up starting with the Bayer announcement . I predict that Very shortly big money will again be flowing into EAPH making EAPH the big play once again except this time it will have sustained new highs based on value and forward sales . New highs will be broken on its way to $.20 cents or higher.
Let's look at some things Easton currently has:
•. $400K in sales in the last quarter from its distribution partners Gedeon Richter who by the way have 11,000 employees and billions in revenues.
•. Sales will now be starting in Central America With Windsor Pharmaceuticals who just received regulatory approval to sell the same products.
• Third product launch shortly at hand through Bayer Pharmaceuticals who are selling VS-Sense in Europe. They now want Mexico and Latin America which Easton currently has the rights to so that will get finalized and once announced watch out.
•. Alliance partners agreement has guaranteed revenues stream secured through property. Medical marijuana approval might soon be announced but they already have contracts announced for the Aggregate business which will not start until they receive a response regarding their medical marijuana initiatives for Canada which will have an answer by the end of this month. By the end of the month we should hear some very good news.
• iBliss is on board with everything which Easton has indicated they appreciated iBliss's patience as they can see the value with Alliance Group.
My friends the big run with new highs is soon here as too many catalysts to ignore. This company will not be undervalued for much longer.
Do your own due diligence and speak to the company about getting accurate information. This includes reading their financial statements and press releases very closely . 3 weeks ago, Easton went up by 50% in a week. That will soon be smalltime returns.
Elfland you are incorrect. It's unfortunate that you are calling any legitimate shareholder a scammer really want to supports the company a scammer and the company a scammer. But it is completely not true. Legitimate companies do not spend cold hard cash.
Thanks TraderJack. I don't know if it's going to explode, but Easton sooner or later he's going to get recognition for the things is doing. Unlike many other companies, they haven't done any type of promotion so not to get in any problems. Sooner or later they will get recognition and it's your price will be reflected. I predict it will be similar to it AMFE but with much bigger volume
HERE ARE THE COLD HARD FACTS OF EAPH. IT CAN BE CHECKED BY READING THEIR FINANCIAL STATEMENTS AND EMAILING THE COMPANY
Most people who post on this chat board are fairly intelligent and can see what others are trying to do. It's obvious that some are jealous and have some type of animosity towards Easton and want them to fail. Unfortunately for them, it's now too late as those one or two individuals will not be able to stop what is going to happen with the company progressing with its business plan. Easton has advanced funds for LEGITIMATE acquisitions that are soon going to generate millions of dollars in profits and has advanced funds towards licensing.
First they tried to say that Gedeon Richter was not real. Well I'm sorry to burst their tiny bubble, Gideon Richter did sign an agreement and is selling product on behalf of themselves and Easton/BMV. They have 11,000 employees and have billions in revenues.
Then they tried to slam Windsor pharmaceuticals. Well Windsor pharmaceuticals just spent a whole year getting regulatory approval for those products and were now successful. Product is going to be delivered in the next few weeks and they will be selling very shortly. People can say what they wish but everyone who is intelligent and knows what is going on when they say something ridiculous. I personally think that it's criminal for someone to say something that is so flagrantly false about any company or any individuals.
To answer some nonsense comments from those types of people, Easton has not had any shares issued in over 2 years. That means zero dilution!
So Easton announced that they were possibly doing something in Jamaica regarding medical marijuana and decided not to do it, SO WHAT! They found something in Canada which is a much much larger market instead . Is there something wrong with that. The Jamaica letter of intent was just that, a letter of intent which they decided not to do. Too many dumb things said by some and shouldn't it be about time that we start talking and asking intelligent questions.
As Easton stated, ALLIANCE / EASTON HAS CONTRACTS IN PLACE FOR THEIR AGGREGATE BUSINESS. ITS GUARANTEED REVENUES FOR EASTON. EASYON HAS THE OPTION TO HO INTO MMJ OR AGGREGATE . THE STOCK IS WAY UNDERVALUED COMPARED TO MANY OTHERS BASED ON FUTURE REVENUES
I predict that Your going to soon get another big run up starting with the Bayer announcement . I predict that Very shortly big money will again be flowing into EAPH making EAPH the big play except this time it will have sustained new highs based on value and forward sales . New highs will be broken on its way to $.20 cents or higher.
Let's look at some things Easton currently has:
•. $400K in sales in the last quarter from its distribution partners Gedeon Richter who by the way have 11,000 employees and billions in revenues.
•. Sales will now be starting in Central America With Windsor Pharmaceuticals who just received regulatory approval to sell the same products.
• Third product launch shortly at hand through Bayer Pharmaceuticals who are selling VS-Sense in Europe. They now want Mexico and Latin America which Easton currently has the rights to so that will get finalized and once announced watch out.
•. Alliance partners agreement has guaranteed revenues stream secured through property. Medical marijuana approval might soon be announced but they already have contracts announced for the Aggregate business which will not start until they receive a response regarding their medical marijuana initiatives for Canada which will have an answer by the end of this month. By the end of the month we should hear some very good news.
• iBliss is on board with everything which Easton has indicated they appreciated iBliss's patience as they can see the value with Alliance Group.
My friends the big run with new highs is soon here as too many catalysts to ignore. This company will not be undervalued for much longer.
Do your own due diligence and speak to the company about getting accurate information instead of listening to things that are not true. This includes reading their financial statements and press releases very closely am I friends, please don't listen to nonsense from jealous people who missed out on the previous runs and profits made. Three weeks ago, Easton went up by 50% in a week. That will soon be smalltime returns.
EAPH WENT UP 50% 3 WEEKS AGO. THAT WAS JUST A TEST. EASTON CAN AND WILL HAVE THE SAME SUCCESS AS OTHERS SUCH AS AMFIL AND SING. EAPH WILL GET THIS SUCCESS THROUGH SOLID NEWS AND SALES AND NOT FROM ANY PROMOTIONAL CAMPAIGNS. THE STOCK WILL TAKE CARE OF ITSELF WITH SOLID NEWS.
EAPH IS HOPEFULLY JUST A FEW SHORT DAYS AWAY FROM A CLOSED AGREEMENT WITH BAYER. ITS NOT IF BUT WHEN THAT HAPPENS.
To all shareholders who previously profited very well on EAPH, LISTEN UP!!
Most people who post on this chat board are fairly intelligent and can see what others are trying to do. It's obvious that some are jealous and have some type of animosity towards Easton and want them to fail. Unfortunately for them, it's now too late as those one or two individuals will not be able to stop what is going to happen with the company progressing with its business plan. Easton has advanced funds for acquisitions that are soon going to generate millions of dollars in profits and has advanced funds towards licensing.
First they tried to say that Gedeon Richter was not real. Well I'm sorry to burst their tiny bubble, Gideon Richter did sign an agreement and is selling product on behalf of themselves and Easton/BMV. They have 11,000 employees and have billions in revenues.
Then they tried to slam Windsor pharmaceuticals. Well Windsor pharmaceuticals just spent a whole year getting regulatory approval for those products and were now successful. Product is going to be delivered in the next few weeks and they will be selling very shortly. People can say what they wish but everyone who is intelligent and knows what is going on when they say something ridiculous. I personally think that it's criminal for someone to say something that is so flagrantly false about any company or any individuals.
To answer some nonsense comments from those types of people, Easton has not had any shares issued in over 2 years. That means zero dilution!
So Easton announced that they were possibly doing something in Jamaica regarding medical marijuana and decided not to do it, SO WHAT! They found something in Canada which is a much much larger market instead . Is there something wrong with that. The Jamaica letter of intent was just that, a letter of intent which they decided not to do. Too many dumb things said by some and shouldn't it be about time that we start talking and asking intelligent questions.
I will say it again, ALLIANCE HAS CONTRACTS IN PLACE FOR THEIR AGGREGATE BUSINESS. ITS GUARANTEED REVENUES FOR EASTON. EASYON HAS THE OPTION TO HO INTO MMJ OR AGGREGATE . THE STOCK IS WAY UNDERVALUED COMPARED TO MANY OTHERS BASED ON FUTURE REVENUES
I predict that Your going to soon get another big run up starting with the Bayer announcement . Very shortly big money will again be flowing into EAPH making EAPH the big play except this time it will have sustained new highs based on value and forward sales . New highs will be broken on its way to $.20 cents or higher.
Let's look at some things Easton currently has:
•. $400K in sales in the last quarter from its distribution partners Gedeon Richter who by the way have 11,000 employees and billions in revenues.
•. Sales will now be starting in Central America With Windsor Pharmaceuticals who just received regulatory approval to sell the same products.
• Third product launch shortly at hand through Bayer Pharmaceuticals who are selling VS-Sense in Europe. They now want Mexico and Latin America which Easton currently has the rights to so that will get finalized and once announced watch out.
•. Alliance partners agreement has guaranteed revenues stream secured through property. Medical marijuana approval might soon be announced but they already have contracts announced for the Aggregate business which will not start until they receive a response regarding their medical marijuana initiatives for Canada which will have an answer by the end of this month. By the end of the month we should hear some very good news.
• iBliss is on board with everything which Easton has indicated they appreciated iBliss's patience as they can see the value with Alliance Group.
My friends the big run with new highs is soon here as too many catalysts to ignore. This company will not be undervalued for much longer.
Do your own due diligence and speak to the company about getting accurate information instead of listening to things that are not true. This includes reading their financial statements and press releases very closely am I friends, please don't listen to nonsense from jealous people who missed out on the previous runs and profits made. Three weeks ago, Easton went up by 50% in a week. That will soon be smalltime returns.
To all shareholders who previously profited very well on EAPH, LISTEN UP!!
Most people who post on this chat board are fairly intelligent and can see what others are trying to do. It's obvious that some are jealous and have some type of animosity towards Easton and their success. Unfortunately for them, it's now too late as voles one or two individuals will not be able to stop what is going to happen with the company progressing with its business plan. Easton has advanced funds for acquisitions that are soon going to generate millions of dollars in profits and has advanced funds towards licensing.
First they tried to say that Gedeon Richter is not real. Well I'm sorry to burst their tiny bubble, Gideon Richter did sign an agreement and is selling product on behalf of themselves and Easton/BMV. They have 11,000 employees and have billions in revenues.
Then they tried to slam Windsor pharmaceuticals. Well Windsor pharmaceuticals just spent a whole year getting regulatory approval for those products and were now successful. Product is going to be delivered in the next few weeks and they will be selling very shortly. People can say what they wish but everyone who is intelligent and knows what is going on when they say something ridiculous. I personally think that it's criminal for someone to say something that is so flagrantly false about any company or any individuals.
To answer some nonsense comments from those types of people, Easton has not had any shares issued in over 2 years. That means zero dilution!
So Easton announced that they were possibly doing something in Jamaica regarding medical marijuana and decided not to do it, SO WHAT! They found something in Canada which is a much much larger market instead . Is there something wrong with that. The Jamaica letter of intent was just that, a letter of intent which they decided not to do. Too many dumb things said by some and shouldn't it be about time that we start talking and asking intelligent questions.
I will say it again, ALLIANCE HAS CONTRACTS IN PLACE FOR THEIR AGGREGATE BUSINESS. ITS GUARANTEED REVENUES FOR EASTON. EASYON HAS THE OPTION TO HO INTO MMJ OR AGGREGATE . THE STOCK IS WAY UNDERVALUED COMPARED TO MANY OTHERS BASED ON FUTURE REVENUES
I predict that Your going to soon get another big run up starting with the Bayer announcement . Very shortly big money will again be flowing into EAPH making EAPH the big play except this time it will have sustained new highs based on value and forward sales . New highs will be broken on its way to $.20 cents or higher.
Let's look at some things Easton currently has:
•. $400K in sales in the last quarter from its distribution partners Gedeon Richter who by the way have 11,000 employees and billions in revenues.
•. Sales will now be starting in Central America With Windsor Pharmaceuticals who just received regulatory approval to sell the same products.
• Third product launch shortly at hand through Bayer Pharmaceuticals who are selling VS-Sense in Europe. They now want Mexico and Latin America which Easton currently has the rights to so that will get finalized and once announced watch out.
•. Alliance partners agreement has guaranteed revenues stream secured through property. Medical marijuana approval might soon be announced but they already have contracts announced for the Aggregate business which will not start until they receive a response regarding their medical marijuana initiatives for Canada which will have an answer by the end of this month. By the end of the month we should hear some very good news.
• iBliss is on board with everything which Easton has indicated they appreciated iBliss's patience as they can see the value with Alliance Group.
My friends the big run with new highs is soon here as too many catalysts to ignore. This company will not be undervalued for much longer.
Do your own due diligence and speak to the company about getting accurate information instead of listening to things that are not true. This includes reading their financial statements and press releases very closely am I friends, please don't listen to nonsense from jealous people who missed out on the previous runs and profits made. Three weeks ago, Easton went up by 50% in a week. That will soon be smalltime returns.
!!EASTON HAS ACQUIRED FINANCING!! Someone can actually ask such a question of where did Easton get their cash. LOLOLOL! Easton has an investor or a few investors who believe enough in Easton to advance $1.7 million in the last few years to acquisition's and licensing of products.
Shareholders should be happy that a private investor has provided Easton with cold hard cash which Easton has used to grow the company. Soon enough, Easton will be in revenues on the exact positions which it has also started generating revenue's on it's licensed woman's diagnostic and treatment Products.
Can we finally start getting some smart questions asked
The future looking good
To all shareholders who previously profited very well on EAPH, LISTEN UP!!
Don't listen to those who know nothing about investing and are not Shareholders. To answer some stupid questions from those types of people, Easton has not had any shares issued in over 2 years. That means zero dilution
so Easton announced that they were possibly doing something in Jamaica regarding medical marijuana and decided not to do it, SO WHAT! They found something in Canada which is a much larger market instead . Is there something wrong with that. The Jamaica letter of intent was just that, a letter of intent which they decided not to do. Too many stupid things said by some ignorant people.
I will say it again, ALLIANCE HAS CONTRACTS IN PLACE FOR THEIR AGGREGATE BUSINESS. ITS GUARANTEED REVENUES FOR EASTON. THE STOCK IS WAY UNDERVALUED COMPARED TO MANY OTHERS
I predict that Your going to soon get another big run up starting with the Bayer announcement . Very shortly big money will again be flowing into EAPH making EAPH the big play except this time it will have sustained new highs based on value and forward sales . New highs will be broken on its way to $.20 cents or higher.
Let's look at some things Easton currently has:
$400K in sales in the last quarter from its distribution partners Gedeon Richter who by the way have 11,000 employees and billions in revenues.
Sales will now be starting in Central America With Windsor Pharmaceuticals who just received regulatory approval to sell the same products.
Third product launch shortly at hand through Bayer Pharmaceuticals who are selling VS-Sense in Europe. They now want Mexico and Latin America which Easton currently has the rights to so that will get finalized and once announced watch out.
Alliance partners agreement has guaranteed revenues stream secured through property. Medical marijuana approval might soon be announced but they already have contracts announced for the Aggregate business which will not start until they receive a response regarding their medical marijuana initiatives for Canada which will have an answer by the end of this month. By the end of the month we should hear some very good news.
IBliss is on board with everything which Easton has indicated they appreciated iBliss's patience as they can see the value with Alliance Group.
My friends the big run with new highs is soon here as too many catalysts to ignore. This company will not be undervalued for much longer.
Do your own due diligence and speak to the company about getting accurate information instead of listening to things that are not true. This includes reading their financial statements and press releases very closely.
To all shareholders who previously profited very well on EAPH, LISTEN UP!!
Don't listen to anyone who knows nothing about anything except smoking too much. To answer some stupid questions from this types of people, so Easton announced that they were possibly doing something in Jamaica regarding medical marijuana. So they made the decision not to do it because they found something in Canada which is a much larger market. Is there something wrong with that. The Jamaica letter of intent was just that, a letter of intent which they decided not to do. They decided not to do it because they found something much better with guaranteed revenues. Alliance has contracts in place for their aggregate business.
I will say it again, ALLIANCE HAS CONTRACTS IN PLACE FIR THEIR AGGREGATE BUSINESS. ITS GUARANTEED REVENUES FOR EASTON. THE STOCK IS WAY UNDERVALUED COMPARED TO MANY OTHERS
Your going to soon get another big run up. It might not start today or tomorrow but very shortly big money will again be flowing into EAPH making EAPH the big play except this time it will have sustained new highs based on value . New highs will be broken on its way to $.20 cents or higher.
Let's look at some things Easton currently has:
$400K in sales in the last quarter from its distribution partners Gedeon Richter who by the way have 11,000 employees and billions in revenues.
Sales will now be starting in Central America With Windsor Pharmaceuticals who just received regulatory approval to sell the same products.
Third product launch shortly at hand through Bayer Pharmaceuticals who are selling VS-Sense in Europe. They now want Mexico and Latin America which Easton currently has the rights to so that will get finalized and once announced watch out.
Alliance partners agreement has guaranteed revenues stream secured through property. Medical marijuana approval might soon be announced but they already have contracts announced for the Aggregate business which will not start until they receive a response regarding their medical marijuana initiatives for Canada. By the end of the month we should hear some very good news.
IBliss is on board with everything which Easton has indicated they appreciated iBliss's patience as they can see the value with Alliance Group.
My friends the big run with new highs is soon here as too many catalysts to ignore. This company will not be undervalued for much longer.
Do your own due diligence and speak to the company about getting accurate information instead of listening to things that are not true. This includes reading their financial statements and press releases very closely.
IBliss is waiting because they see the value in everything else that Easton has. If you were able to get shares in Microsoft which obviously is not the same example, I'm sure you would wait as well. When you have contracts in place through alliance group and you're making money through multibillion dollar pharmaceutical companies with 11,000 employees, I would say Easton has a pretty good chance to succeed. I would also say that this share price they are currently sitting at represents and undervalued stock.
People need to listen to the responses from the company and from intelligent shareholders. Those are the ones who actually did do diligence and know what they are talking about. People should also look at the financial statements and read closely what they stated. From there you will know that this company is undervalued.
Why would Bayer pharmaceuticals want to do a deal with small Easton, it's because Bayer are already selling the same product throughout all of Europe. They now want to sell it in Mexico and other parts of Latin America. Who has the rights, it's small Easton. It's taking longer than usual in the company is just as frustrated as everyone else, but everyone is fairly confident that the Bayer agreement will get completed.
Soon enough we should also see revenues coming in through alliance group. By the end of the month Easton in alliance may have something very big to announce in regards to medical and recreational marijuana.
To all longs!! Listen up to facts!! Anyone having the nerve to actually think EAPH announced Gedeon Richter was a lie is really trying their best to drop the stock price at all costs. Gedeon Richter is a company with 11,000 employees who had offices and sales all around the world. Why the hell would accompany like this not sue Easton if what was said is a lie. I mean just think about how stupid that sounds.
As much as they want to drop Easton's stick because they are upset they missed out on big profits in the past, it won't work.
- EAPH / BMV has 2 products with Gedeon Richter. Why? Because EAPH bought the licensing rights with cold hard cash.
- Bayer is selling VS- Sense all across Europe. So now they want it for Mexico and Latin America. That's a fact. Who owns the licensing rights for those territories, its EAPH because they bought it with cold hard cash.
- why is this true, because FINRA does reviews of all press releases. Does everyone understand this now.
- Easton paid $1,000,000 to Alliance group because they have closed contracts. The end of September will bring some very interesting news on medical/ recreational marijuana and other contracts.
IBliss is waiting in the wings and their revenues will soon be pry of Easton's.
Everything else is just plain garbage. It makes me sick.
Soon enough we will have the big run up and it will be sweet to watch.
To all shareholders who previously profited very well on EAPH, LISTEN UP!!
Your going to soon get another big run up. It might not start today or tomorrow but very shortly big money will again be flowing into EAPH making EAPH the big play except this time it will have sustained new highs based on value . New highs will be broken on its way to $.20 cents or higher.
Let's look at some things Easton currently has:
$400K in sales in the last quarter from its distribution partners Gedeon Richter who by the way have 11,000 employees and billions in revenues.
Sales will now be starting in Central America With Windsor Pharmaceuticals who just received regulatory approval to sell the same products.
Third product launch shortly at hand through Bayer Pharmaceuticals who are selling VS-Sense in Europe. They now want Mexico and Latin America which Easton currently has the rights to so that will get finalized and once announced watch out.
Alliance partners agreement has guaranteed revenues stream secured through property. Medical marijuana approval might soon be announced but they already have contracts announced for the Aggregate business which will not start until they receive a response regarding their medical marijuana initiatives for Canada. By the end of the month we should hear some very good news.
IBliss is on board with everything which Easton has indicated they appreciated iBliss's patience as they can see the value with Alliance Group.
My friends the big run with new highs is soon here as too many catalysts to ignore. This company will not be undervalued for much longer.
Do your own due diligence and speak to the company about getting accurate information instead of listening to things that are not true. This includes reading their financial statements and press releases very closely.
To all shareholders who previously profited very well on EAPH, LISTEN UP
Your going to soon get another big run up. It might not start today or tomorrow but very shortly big money will be flowing into EAPH. New highs will be broken on its way to $.20 cents or higher.
Let's look at some things Easton currently has:
$400K in sales in the last quarter from its distribution partners Gedeon Richter who by the way have 11,000 employees and billions in revenues.
Sales will now be starting in Central America With Windsor Pharmaceuticals who just received regulatory approval to sell the same products.
Third product launch shortly at hand through Bayer Pharmaceuticals who are selling VS-Sense in Europe. They now want Mexico and Latin America which Easton currently has the rights to so that will get finalized and once announced watch out.
Alliance partners agreement has guaranteed revenues stream secured through property. Medical marijuana approval might soon be announced but they already have contracts announced for the Aggregate business which will not start until they receive a response regarding their medical marijuana initiatives for Canada. By the end of the month we should hear some very good news.
IBliss is on board with everything which Easton has indicated they appreciated iBliss's patience as they can see the value with Alliance Group.
My friends the big run with new highs is soon here as too many catalysts to ignore. This company will not be undervalued for much longer.
Do your own due diligence and speak to the company about getting accurate information instead of listening to things that are not true. This includes reading their financial statements and press releases very closely.
Me and my business partners did write and check. A few checks or wires to be frank. I believe in Alliance group and their contracts. As Easton stated, they have contracts and good ones Pending and have ownership in part of the property . They can't start revenues on those contracts until they hear back regarding the medical marijuana project so not to put it in any jeopardy.
I don't care if people sell or where it goes because I know the future is bright for woman's diagnostic and treatment products with a multinational pharmaceutical company and a pending launch with a huge German based multinational company. Anyone wishing to try and keep it down can do so but they're going to be buying it back very soon
To All Longs and Not So Long. Yesterday's release was very positive because it's a new source of revenues starting now, but Easton has much bigger things to announce. Company is expecting the Bayer contract this week. But everyone should realize that the pharmaceutical companies work on their own time especially the big ones. Whether it's an extra day or an extra week or next or a few weeks, they have told you that they expect it and it's eminent . Now is not the time to bail on a company who is not anywhere close to where it should be trading.
Yesterday's Windsor pharmaceuticals announcement was significant because they waited one year to have these Products approved. They now have all approvals and are now selling in Central America, Mexico and soon other territories not yet announced.
If anyone believes that their press releases with alliance group are not real and that they haven't put any money into anything,, then go ahead and sell. But only a fool would believe they are posting something that is fraudulent that could put them in jail.
To all shareholders who profited very well on EAPH, LISTEN UP
Your going to soon get another big profit run up. It might not start today but very shortly big money will be flowing into EAPH. New highs will be broken on its way to $.20 cents or higher.
Let's look at some things Easton currently has
$400K in sales in the last quarter from its distribution partners Gedeon Richter who by the way have 11,000 employees and billions in revenues.
Sales will now be starting in Central America With Windsor Pharmaceuticals who just received regulatory approval to sell the same products.
Third product launch shortly at hand through Bayer Pharmaceuticals who are selling VS-Sense in Europe. They now want Mexico and Latin America which Easton has the rights to.
Alliance partners agreement is guaranteed revenues stream secured through property. Medical marijuana approval might soon be announced but they already have contracts announced for the Aggregate business.
IBliss is on board with everything.
My friends the big run with new highs is soon here as too many catalysts to ignore. This company will not be undervalued for much longer.
GUARANTEED REVENUES With alliance group.
REVENUES WITH GEDEON RICHTER for 2 products, a company with 11,000 employees.
Easton is way way undervalued right now but not for long. It's just a short matter of time before everyone jumps back on board for a huge run.
Easton tweeted that iBliss is completely on board with the delay and with the acquisition and the JV with alliance partners.
My sources tell me, that Easton will have a significant announcement regarding their woman's health product sometime this week which would've been announced last week if not for the huge earthquake in Mexico City. Hopefully that press release will have the name of Bayer pharmaceuticals on it who just happens to be selling the exact same product in Europe so goes without saying that this is a done deal with Bayer.
What does that represent in revenues and IN market cap. MUCHO DOLLARS.
Revenues are GUARANTEED With alliance group. Hopefully those will be revenues with medical marijuana. If not the aggregate contracts will make just as much money if not more.
Easton is way way undervalued right now but not for long. It's just a short matter of time before everyone jumps back on board.
Easton tweeted that iBliss is completely on board with the delay and with the acquisition and the JV with alliance partners.
My sources tell me, that Easton will have a significant announcement regarding their woman's health product sometime next week. Hopefully that press release will have the name of Bayer pharmaceuticals on it who just happens to be selling the exact same product in Europe. Obviously Bayer once the product for Latin America an suv for Meric
!!GREAT NEWS YESTERDAY AND MUCH MORE TO COME!! The big run is coming. I predicted the end of September and I still stand by that.
Yesterday's press release showed that not only do they have cash but they are spending it towards revenue generating acquisitions. They have revenues with 2 products and a third through Bayer is close at hand. The ups and downs of the stock price is not important.
Real company with real products. An in case sir idiot try's to say that Easton only has $3K in the bank all you have to do is look at the financial statements to see how much money has been raised and spent.
The profits to any long shareholder is soon at hand.
!!EASTON ADVANCES $1,000,000 TO ACQUIRE GUARANTEED REVENUES CONTRACTS IN HAND!!
This is on top of what they already have with their women's diagnostic and treatment products. Already $400,000 in sales through Gedeon Richter with a third product set to be announced any day
Bayer pharmaceuticals is possibly tomorrow or a few short days away. This should be a $100 million company and not a $25 million company. Look at all the other companies that have nothing. Amfe is a great example.
EAPH - Take a look at this undervalued stock.
Easton Pharmaceuticals Announces $1,000,000 cdn In Payments Toward Alliance Group JV / Partnership Agreement; Announces $8,000,000 cdn Aggregate LOI Contract
TORONTO, ON--(Marketwired - Sep 5, 2017) - Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), is pleased to announce, pursuant to its previously announced Closing Agreement with Canadian based 124123 Ontario Inc. (O/A - Alliance Group), Easton has advanced $1,000,000 cdn in payments to Alliance Group. Alliance executes $8,000,000 cdn aggregate LOI contract on its 90 acres of zoned industrial land.
Easton Pharmaceuticals has thus far paid $1,000,000 cdn in cash out of $1.3 million cdn to Toronto based 124123 Ontario Inc. (o/a - Alliance Group) to acquire a 50% property ownership interest in 45 acres of agriculturally zoned land north of Toronto, Ontario, Canada and into a business to cultivate, produce and facilitate the sale of its production of medical / recreational marijuana and other revenue producing businesses on a co-managed basis. Alliance has initiated the process to legally grow medical / recreational marijuana with all levels of government in Canada including federal and provincial ministers, municipal governments and law enforcement officials. Alliance anticipates positive news within the next 30 to 45 days regarding its medical / recreational marijuana license exemptions. At Easton option, until such time that approvals and revenues can be legally generated with cultivating and distributing medical / recreational marijuana in Canada, the agreement calls for Easton to receive 50% of all revenues on Alliance's Aggregate businesses, which includes recycling, manufacturing of various industrial products, waste management services, cement, asphalt and other type aggregate products. Alliance Partners announces that it signed a letter of intent for an approximate $8,000,000 cdn contract with a local construction company which will convert to a final closing agreement once environmental and soil analysis samples have completed testing. Alliance is anticipating and planning for a closed contract by September 30th of this year, but delays in samples may extend this time frame.
In other developments, Easton Pharmaceuticals will provide an update in the coming days toward its previous announcement of a possible launch of a third product through the closing of a third sub-distribution agreement with a Switzerland based multi-national drug company.
About Easton Pharmaceuticals
Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. The Company previously developed and owned an FDA-approved wound-healing medical drug and currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions that are all in various stages of development and approval. Easton has partnered with BMV Medica and together own the exclusive distribution rights in Mexico and Latin America for patented women's diagnostic / treatment products "Gynofit," "AmnioSense," "VS-Sense" and two generic cancer drugs " Docetaxel" Paclitaxel." Easton / BMV have sub-licensed products "Gynofit" and "AmnioSense" with multi-national pharmaceutical company Gedeon Richter Plc of Hungary. The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of other drugs and Cannabidiol extracts. Easton has closed on an agreement to acquire 100% of iBliss Inc., a leading e-liquid vapour producer and distributor with international sales and has entered into a 50 / 50 JV Partnership agreement with Alliance Partners to cultivate, grow, harvest, distribute and sell medical / recreational marijuana for Canada.
For More Information On Easton and Affiliated and Partner Company's Visit:
http://www.eastonpharmaceuticalsinc.com
http://www.richter.hu/en-US/Pages/default.aspx
http://www.bmvmedica.net
http://iblissvapor.com
http://finance.yahoo.com/q?s=eaph
https://twitter.com/eastonpharma
!!LONG AND STRONG!! LETS LOOK AT ALL THE GREAT THINGS KARRAS HAS DONE AS CEO!!
What did Easton's financial statement show, let's look into it, for those who can read, it shows $400,000 in sales from one product launch in 3 months with a multibillion dollar pharmaceutical company as its partner (Gedeon Richter). It also shows they are launching a second product in September and a payment received for a purchase order from A multibillion dollar pharmaceutical company called Gedeon Richter. Look at Gedeon products and financial statements and then you see through all the lies from Doggy.
What else does it show, it shows $1.7 million in capital raised and spent for licensing and acquisition's which are now generating revenue's and have contracts in hand. Has there been any dilution? how can you have dilution when there hasn't been one share issued since July 2015. LOL!
Now they have completed an acquisition where they own property valued at $8 million. Now we have a $6 million contract in hand with the possibility of medical marijuana being is leading product within a month with revenues guaranteed.
IBliss is a done deal. Revenues will follow as mid September should see a big development.
Bayer Pharmaceuticals announcement is possibly this week.
As the company has stated, don't listen to lies. Do your own due diligence and listen to news and facts that's from real sources.
Soon enough, and I think very very soon, I predict Easton will no longer be under priced compared to other companies like AMFIL and SING and many others. Easton has been an undervalued underdog for too long, but I promise you one thing, every dog has its day and Easton's day is coming fast.
EASTONS FINANCIALS LOOK GOOD. IT DOESNT HAVE ANY MISINFORMATION ON IT AND IT SHIWS REVENUES, MONEY SPENT, AND PRODUCTS LAUNCHED
What does Easton's financial statement show, let's look into it, for those who can read, it shows $400,000 in sales from one product launch in 3 months with a multibillion dollar pharmaceutical company as its partner. It also shows they launched a second product in September and a payment received for a purchase order from A multibillion dollar pharmaceutical company. What else does it show, it shows $1.7 million in capital raised and spent for licensing and acquisition's which are now generating revenue's and have contracts in hand. Has there been any dilution, how can you have dilution when there hasn't been one share issued since July 2015.
Now they have completed an acquisition where they own property valued at $8 million. Now we have a $6 million contract in hand with the possibility of medical marijuana being is leading product.
IBliss is a done deal. Revenues will follow with that.
As the company has stated, don't listen to lies. Do your own due diligence and listen to news and facts that's from real sources.
Soon enough, and I think very very soon, I predict Easton will no longer be under priced compared to other companies like AMFIL and SING and many others. Easton has been an undervalued underdog for too long, but I promise you one thing, every dog has its day and Easton's day is coming fast.
!!NO NEW SHARES ISSUED SINCE JULY 2015!! NO DILUTION.
To all those who don't understand anything about financial statements, dilution only happens when you issue shares. They have raised $1.7 million dollars for licenses and acquisitions which are now bringing revenues to the company. Eventually that money will have to be repaid either in stock issuances or a share of the profits as no one advances money for free. But right now there is no dilution as the investors are clearly behind the company
Bayer pharmaceuticals is a pending announcement which the company has already stated. That would be the third product launch in the second from a huge, I mean huge pharmaceutical company worth hundreds of billions of dollars in the market cap.
GO EAPH GO. It's a matter of time before the community realizes that Easton is for real and that it should be more at $.30 then $.03 cents.
BAYER, GEDEON RICHTER, ALLIANCE AND IBLISS MAKES EAPH A LONG TERM HOLD
Evan Karras has done absolutely everything possible to try and build shareholder value without dilution. ONE just needs to go to the financial statements. Take a look at the last share issuances for the company and it will clearly state July 2015.
In addition, Easton has advanced approximately $1.5 million to licensing rights/acquisition's over the past two years with revenues now being produced. Easton is now into revenues with a multibillion dollar pharmaceutical company as its partner called Gedeon Richter. Go to their website and take a look at what kind of company Gedeon Richter is. Look at their sales and their products. Why does a company like this get involved with Easton if it was not a legitimate company with legitimate Products.
Easton has closed with IBliss and it states in their financial statements that they expect to start receiving iBliss's revenues by the middle of September. They wanted to close with alliance group 1st. I suspect you'll see a slew of incredibly positive press release next week highlighting how their business is moving forward with cash payments towards these acquisitions and with new product launches with Bayer.
Don't listen to deception . Evan Karras has so far done a very good job. And if we can get the announcement from a closed agreement with Bayer pharmaceuticals, this will be a $.20 stock in the near term. Add contracts with Alliance then this is a $.30 cent stock. Look at AMFE as an example.
LONG AND STRONG
TRUTH VS DECEPTIVE LIES....THESE ARE THE FACTS.
Evan Karras has not taken one dime from Easton. He has not taken a paycheck and has not taken any payments made to Alliance Group. Secondly, he has done absolutely everything possible to try and build shareholder value without dilution. Anyone with half a brain, just needs to go to the financial statements. Take a look at the last share issuances for the company and it will clearly state July 2015.
In addition, Easton has advanced approximately $1.5 million to licensing rights/acquisition's over the past two years with Robbie news now being produced. Easton is now into revenues with a multibillion dollar pharmaceutical company as its partner called Gedeon Richter. Go to their website and take a look at what kind of company getting Richter is. Look at their sales in their products. Why does a company like this get involved with Easton if it was not a legitimate company with legitimate Products.
Easton has closed with IBliss and it states in their financial statements that they expect to start receiving iBliss's revenues by the middle of September. I'm certain that the delays have been, but they want to close with alliance group 1st. I suspect you'll see a pretty positive press release later this week or early this week highlighting how their business is moving forward with cash payments towards these acquisitions.
Don't listen to the lies and deception of people who don't show any facts. Evan Karras has so far done a very good job. And if we can get the announcement from a closed agreement with Bayer pharmaceuticals, this will be a $.20 stock in the near term.
LONG AND STRONG
GREAT NEWS NEXT WEEK TO FURTHER DEMONSTRATE THIS COMPANY IS MOVING FORWARD IN A BIG WAY.
REVENUES THROUGH BILLION DOLLAR GEDEON RICHTER HAVE STARTED COMING IN.
THIRD PRODUCT LAUNCH CONTRACT EXPECTED VERY SOON WITH HUGE MULTI-NATIONAL BAYER PHARMACEUTICALS. THAT ANNOUNCEMENT WILL BRING IN ALL THE BIG FUNDS AS EASTON WILL ALSO BE ANNOUNCING AN AUDIT VERY SOON
IBLISS REVENUES TO START IN THE NEXT QUARTER AS PER FINANCIAL STATEMENTS.
ALLIANCE CONTRACT IS JUST THE FIRST. ALLIANCE AND EASTON WILL HAVE TENS OF MILLIONS IN CONTRACTS WITH ANOTHER CONTRACT ANNOUNCEMENT SHORTLY.
SO FAR ITS ZERO DILUTION FOR ALL SHAREHOLDERS.
!!GO EAPH !!
!!ZERO DILUTION!! !!EASTON TWEETED NEWS!! EASTON IS LOOKING TO GET NEWS OUT FOR NEXT WEEK. AS FOR WHATS REAL AND WHAT ARE LIES, EASTON HAS ZERO DILUTION AS PER THEIR FINANCIAL STATEMENTS. NOVNEW SHARES ISSUED SINCE JULY OF 2015. THAT MEANS ZERO DILUTION WHIKE DURING THAT TIME THEY HAVE PAID $1.5 MILLION FOR LICENSES WHICH ARE GENERATING REVENUES AND FOR NEW BUSINESSES WHICH HAVE CONTRACTS IN HAND.
EVAN KARRAS IS DOING A GREAT JOB ON ALL FRONTS INCLUDING IBLISS. THIS STOCK IS WAY UNDERVALUED BUT THAT WILL SOON CHANGE.
!!NEWS OUT!! REVENUES ARE ACCURATE. IT WAS FIRST DESCRIBED AS A RECEIVABLE BUT EAPH WAS THEN GIVEN APPROVAL FROM ITS ACCOUNTANT TO CLASSIFY IT AS SALES WHICH IS WHAT IT IS.
GREAT CONTRACT ANNOUNCEMENT TODAY. I THINK WE CAN EXPECT MANY MORE LIKE THIS. THIS GUARANTEES CONSTANT REVENUES TO EASTON WITH HUGE PROFIT MARGINS. BUT IF THEY GET MEDICAL MARIJUANA LICENSE THEN OF COURSE EASTON HAS A TOUGH DECISION WHICH IS WHICH BUSINESS MAKES MORE MONEY AND WHICH ONE TO CHOOSE. ITS A GOOD PROBLEM TO HAVE.
EVAN KARRAS IS DOING A GREAT JOB BRINGING IN SHAREHOLDER VALUE.
WAIT TILL THE BAYER ANNOUNCEMENT IS MADE. I HEAR IT COULD BE AS EARLY AS NEXT WEEK.
!!SALES SALES!! FINANCIAL STATEMENTS SHOW $400K IN SALES FROM GEDEON RICHTER. THAT IS ONLY FROM COUPLE OF MONTHS OF LAUNCHING PRODUCT. GEDEON RICHTER WHICH IS A MULTI-BILLION DOLLAR PHARMACEUTICAL COMPANY HAS 2 PRODUCTS FROM EAPH WITH DISCUSSIONS TO INCLUDE SELLING IN BRAZIL AND OTHER COUNTRIES.
BAYER PHARMACEUTICALS, A HUGE 200 BILLION DOLLAR COMPANY IS FINALIZING ITS CONTRACT WITH EASTON / BMV. ONCE THE NAME BAYER IS ANNOUNCED RIGHT BESIDE SMALL EAPH , IT WILL MAKE PUNY EASTON NOT SO SMALL ANYMORE. CAN THE PINHEADS UNDERSTAND THAT. ONCE THEY ANNOUNCE CASH PAYMENT AND ROYALTIES ON SALES WITH BAYER ITS OVER.
TOMORROWS POSSIBLE NEWS IS ABOUT EITHER BAYER OR SOMETHING ELSE WHICH COULD BE JUST AS BIG IN VALUE.
EAPH IS A LONG TERM VALUE HOLD
GREAT NEWS EXPECTED THIS WEDNESDAY. I SUSPECT A CONTRACT ANNOUNCEMENT. PATIENCE IS THE KEY. THE STOCK WILL GO UP AND DOWN BUT THE LONG TERM TREND IS UP. EVAN KARRAS IS MAKING SIME GREAT MOVES AND DECISIONS. ITS ALL SOON GOING TO CIME TOGETHER IN A HUGE WAY.
BIG CONTRACT ANNOUNCEMENT COULD POSSIBLY BE READY FOR NEXT WEDNESDAY.
!!GET READY!!
Easton received $400,000 in purchase orders in the last quarter which was its first quarter of launching a product. In September they launch a second product.
Bayer Pharmaceuticals wants very badly to do a deal to get Easton's third product (VS SENSE) Which will be completed and announced very shortly.
They closed on IBliss and the next quarterly will show their revenues.
Now they have acquired an Alliance property for medical marijuana and other businesses where they could possibly start producing within the next 30 to 60 days with an anticipated approval by regulators.
If that does not tell you that the stock is vastly under priced then you're a fool. I predicted by the end of September that the stock will be at $.20 and I am still sticking to that. In fact it has started.
EASTON HAS RAISED AND SPENT $1.3 MILLION ON ACQUIRING LISCENCES FROM REPUTABLE PHARMACEUTICAL COMPANYS AND ACQUISITIONS. THAT AGAIN IS $1.3 MILLION PAID TO COMMON SENSE WHO IS A COMPANY THAT HAS A CONTRACT WITH BAYER PHARMACEUTICALS.
EASTON NOW HAS REVENUES FROM 2 OF THOSE LISCENCED PRODUCTS (GYNOFIT AND AL-SENSE) WHICH THEY HAVE NOW CLOSED ON 2 SUB DISTRIBUTION AGREEMENTS WITH GEDEON RICHTER FOR. GEDEON RICHTER IS A MULTI-BILLION DOLLAR PHARMACEUTICAL COMPANY. YET THE BUFOONS LIKE TO HAVE YOU BELIEVE EASTON IS A SCAM. THE REAL SCAM IS THE PEOPLE WHO HAVE THE GALL TO LIE AND MAKE THOSE CLAIMS WHO DONT KNOW HOW TO READ FINANCIAL STATEMENTS OR KNOW WHAT IT MEANS, EASTONS QUARTERLY STATEMENTS AND PRESS RELEASES SHOW REAL DOLLARS SPENT AND PAID.
WHAT WILL THOSE LIERS SAY WHEN EASTON ANNOUNCES A THIRD SUB DISTRIBUTION AGREEMENT FOR VS-SENSE WITH BAYER PHARMACEUTICALS.
THEY NOW PURCHASED A PROPERTY AND A REVENUE GENERATING BUSINESS THAT IS ALSO CLOSE TO POSSIBLY CULTIVATING MEDICAL MARIJUANA. WHETHER IT DOES KEGALLY GROW AND SELL MARIJUANA EASTON WILL EARN REVENUES FROM THE OTHER BUSINESSES. THEY ALSO HAVE COLLATERAL FROM THE PROPERTY.
THOSE ARE THE FACTS SO DONT LISTEN TO LIES FROM FOOLS.